Overview
Special blood products are standard components modified to address a specific clinical risk for a specific patient population: irradiation (TA-GVHD risk), CMV-safe selection (CMV transmission risk), washing (severe allergic/IgA-related reaction risk), phenotype-matching (alloimmunization risk), and aliquoting (volume-restricted patients). Application is driven by order and institutional policy, not laboratory default assumption.
Classification
| Special attribute | Population protected |
|---|---|
| Irradiated | Severely immunocompromised patients at risk for transfusion-associated GVHD |
| CMV-safe | CMV-seronegative/at-risk patients per institutional policy |
| Washed | Patients with severe allergic reactions or IgA-related concerns per criteria |
| Phenotype-matched | Patients with or at high risk for multiple/clinically significant alloantibodies |
| Aliquoted | Patients requiring smaller-volume transfusions (commonly neonatal/pediatric) |
Morphologic Features
Not a cell-morphology topic, this is a special-product stewardship and verification reference.
Laboratory Characteristics
- Distinct unit labeling/documentation for each special attribute, verified against the order before issue
- Irradiated and washed units carry adjusted (often shortened) expiration per institutional policy
- Phenotype-matched units require antigen-typing verification against the required phenotype before issue
- Aliquoted units require divided-unit labeling and independent expiration tracking
Reference Intervals
Not applicable, qualitative stewardship reference. Exact eligibility criteria, irradiation dose, wash protocols, phenotype-matching extent, and expiration adjustments are institution-specific and governed by current AABB/regulatory standards; verify against current SOP.
Clinical and Laboratory Significance
Special attributes are not general safety upgrades, each targets a distinct mechanism of harm. Applying the wrong attribute, or none when one is indicated, does not provide a generic safety margin; it either fails to address the actual risk or consumes limited inventory without benefit.
Differential Considerations
Distinguish which risk each attribute addresses: TA-GVHD (irradiation) vs. CMV transmission (CMV-safe) vs. severe allergic/IgA reaction (washed) vs. alloimmunization (phenotype-matched), these are non-overlapping indications, not interchangeable safety measures.
Comparison Tables
Special-attribute decision scenarios
| Situation | Laboratory action |
|---|---|
| Order specifies a special attribute | Verify inventory and apply exactly as ordered; confirm labeling before issue |
| Order silent, documented history suggests attribute is indicated | Clarify with ordering clinician before issuing standard product |
| No order and no history suggesting need | Issue standard product; do not apply attribute proactively |
| Special-requirement flag present in patient record | Cross-check every future order against the flag per institutional policy |
Classification Frameworks
Not applicable, laboratory product-stewardship workflow, not a WHO disease classification.
Laboratory Notes
- Match the attribute to the documented indication, over-application and under-application are both stewardship failures
- A history-order mismatch for a special attribute is a clarification trigger, handled like any other order ambiguity
- Verify the correct attribute is documented on the specific unit before issue, do not assume from inventory location
References
Authoritative textbooks, guidelines, and reviews supporting this reference entry. Verify reference intervals, critical limits, and reflex criteria against institutional protocols and current guideline editions.
Textbooks
- Cohn CS, Delaney M, Johnson ST, Katz LM, eds. Technical Manual. 21st ed. AABB; 2023.
- Harmening DM. Modern Blood Banking & Transfusion Practices. 7th ed. F.A. Davis; 2019.
- McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Elsevier; 2021.
CLSI and Professional Guidelines
- AABB. Standards for Blood Banks and Transfusion Services (verify current edition and institutional adoption).
- World Health Organization. Blood safety and availability / transfusion guidance (verify current WHO publication and institutional adoption).
Frequently Asked Questions
Common questions about using this Special Blood Products additional test references Medical Laboratory Library reference in Medical Laboratory Science education.
What is the Special Blood Products laboratory reference?
Special Blood Products is a Additional Test References entry in the LabPedia Medical Laboratory Library, written for Medical Laboratory Science reference lookup.
How should students use this medical laboratory encyclopedia page?
Read the structured sections for quick orientation, then follow related links into Academy lessons or Challenge Center practice when you need teaching or assessment.
Does this page replace laboratory textbooks?
No. It is a concise educational laboratory reference. Use recognized laboratory medicine sources and your institutional procedures for definitive practice decisions.
Where can I find related laboratory tests?
Use related links on this page when present, or browse Laboratory Library discipline catalogues for laboratory tests and interpretation references.
Is this content part of Medical Laboratory Education on LabPedia?
Yes. Library references support Medical Laboratory Education alongside Academy courses, medical laboratory quizzes, and laboratory case studies.
Can reference details vary between laboratories?
Yes. Methods, intervals, and reporting conventions vary. Always confirm details against your laboratory’s current protocols.
How do I return to Library search or categories?
Use breadcrumbs to open the Library hub, discipline catalogues, or other reference collections for continued medical laboratory resource browsing.